Related Experiment Videos
Interactions of combretastatin, a new plant-derived antimitotic agent, with tubulin
Biochemical Pharmacology
|December 15, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Analysis of CT features of 15 children with 2019 novel coronavirus infection].
Zhonghua er ke za zhi = Chinese journal of pediatrics·2020
[Analysis of CT features of 15 Children with 2019 novel coronavirus infection].
Zhonghua er ke za zhi = Chinese journal of pediatrics·2020
[The clinical characteristics of the evoked nystagmus in the non-affected side during Dix-Hallpike test in the unilateral posterior semicircular canal benign paroxysmal positional vertigo].
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2018
[Preliminary analysis of the effects of individualized sound therapy on chronic subjective tinnitus].
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2018
Glucohexaose-induced protein phosphatase 2C regulates cell redox status of cucumber seedling.
Journal of biosciences·2018
3-Methoxychrysazin suppresses RANKL-induced osteoclastogenesis by modulating Notch2 signaling.
Biochemical pharmacology·2026
Prolactin receptor signaling in liver homeostasis and disease.
Biochemical pharmacology·2026
The expression window as a safety parameter for mRNA medicines.
Biochemical pharmacology·2026
Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR-based metabolomic deciphering of ligand interactions.
Metabolomics : Official journal of the Metabolomic Society·2026
Design, synthesis, and evaluation of fluorescent probes targeting DNA polymerase theta (Polθ) for inhibitor screening and cellular imaging.
European journal of medicinal chemistry·2026
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
ACS pharmacology & translational science·2026